1
Jong, M, Oskam, MJ, Sep, S J S, Ozcan, Behiye, Rutters, F, Sijbrands, EJG, Elders, PJM, Siegelaar, SE, deVries, JH, Tack, CJ, Schroijen, M, de Valk, HW, Abbink, EJW, Stehouwer, CD, Jazet, I, Wolffenbuttel, BH, Peters, SA, Schram, MT (Miranda)
Veröffentlicht in: Jong , M , Oskam , MJ , Sep , S J S , Ozcan , B , Rutters , F , Sijbrands , EJG , Elders , PJM , Siegelaar , SE , deVries , JH , Tack , CJ , Schroijen , M , de Valk , HW , Abbink , EJW , Stehouwer , CD , Jazet , I , Wolffenbuttel , BH , Peters , SA & Schram , MT 2020 , ' Sex differences in cardiometabolic risk factors, pharmacological treatment and risk factor control in type 2 diabetes: findings from the Dutch Diabetes Pearl cohort ' , Bmj Open Diabetes Research & Care , vol. 8 , no. 1 , e001365 . https://doi.org/10.1136/bmjdrc-2020-001365;
2020
Veröffentlicht in: Jong , M , Oskam , MJ , Sep , S J S , Ozcan , B , Rutters , F , Sijbrands , EJG , Elders , PJM , Siegelaar , SE , deVries , JH , Tack , CJ , Schroijen , M , de Valk , HW , Abbink , EJW , Stehouwer , CD , Jazet , I , Wolffenbuttel , BH , Peters , SA & Schram , MT 2020 , ' Sex differences in cardiometabolic risk factors, pharmacological treatment and risk factor control in type 2 diabetes: findings from the Dutch Diabetes Pearl cohort ' , Bmj Open Diabetes Research & Care , vol. 8 , no. 1 , e001365 . https://doi.org/10.1136/bmjdrc-2020-001365;
2020
2
van Oort, S., Rutters, F., Warlé-van Herwaarden, M. F., Schram, M. T., Stehouwer, C. D., Tack, C. J., Abbink, E. J., Wolffenbuttel, B. H., van der Klauw, M. M., DeVries, J. H., Siegelaar, S. E., Sijbrands, E. J., Özcan, B., de Valk, H. W., Silvius, B., Schroijen, M. A., Jazet, I. M., van Ballegooijen, A. J., Beulens, J. W.J., Elders, P. J., Kramers, C.
Veröffentlicht in: van Oort , S , Rutters , F , the Diabetes Pearl from the Parelsnoer Initiative , Warlé-van Herwaarden , M F , Schram , M T , Stehouwer , C D , Tack , C J , Abbink , E J , Wolffenbuttel , B H , van der Klauw , M M , DeVries , J H , Siegelaar , S E , Sijbrands , E J , Özcan , B , de Valk , H W , Silvius , B , Schroijen , M A , Jazet , I M , van Ballegooijen , A J , Beulens , J W J , Elders , P J & Kramers , C 2021 , ' Characteristics associated with polypharmacy in people with type 2 diabetes : the Dutch Diabetes Pearl cohort ' , Diabetic Medicine , vol. 38 , no. 4 , e14406 . https://doi.org/10.1111/dme.14406;
2021
Veröffentlicht in: van Oort , S , Rutters , F , the Diabetes Pearl from the Parelsnoer Initiative , Warlé-van Herwaarden , M F , Schram , M T , Stehouwer , C D , Tack , C J , Abbink , E J , Wolffenbuttel , B H , van der Klauw , M M , DeVries , J H , Siegelaar , S E , Sijbrands , E J , Özcan , B , de Valk , H W , Silvius , B , Schroijen , M A , Jazet , I M , van Ballegooijen , A J , Beulens , J W J , Elders , P J & Kramers , C 2021 , ' Characteristics associated with polypharmacy in people with type 2 diabetes : the Dutch Diabetes Pearl cohort ' , Diabetic Medicine , vol. 38 , no. 4 , e14406 . https://doi.org/10.1111/dme.14406;
2021